Cancer stem cells are thought to share many characteristics with their normal stem cell counterparts, raising concerns about the ability to selectively target them. A new study shows that Dclk1 marks cancer, but not normal, stem cells in the intestine and that targeting this population results in adenoma collapse without affecting normal tissue.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Suppressing STAT5 signaling affects osteosarcoma growth and stemness
Cell Death & Disease Open Access 24 February 2020
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Clevers, H. Nat. Med. 17, 313–319 (2011).
Nakanishi, Y. et al. Nat. Genet. 45, 98–103 (2013).
May, R. et al. Stem Cells 26, 630–637 (2008).
Gerbe, F., Brulin, B., Makrini, L., Legraverend, C. & Jay, P. Gastroenterology 137, 2179–2180 (2009).
Barker, N. et al. Nature 449, 1003–1007 (2007).
Schepers, A. G. et al. Science 337, 730–735 (2012).
Polakis, P. Curr. Opin. Pharmacol. 5, 382–387 (2005).
Tian, H. et al. Nature 478, 255–259 (2011).
Chen, J. et al. Nature 488, 522–526 (2012).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors are employees of Genentech, Inc., and F.J.d.S. owns shares of Roche.
Rights and permissions
About this article
Cite this article
Metcalfe, C., de Sauvage, F. A tumor-specific stem cell. Nat Genet 45, 7–9 (2013). https://doi.org/10.1038/ng.2502
Published:
Issue Date:
DOI: https://doi.org/10.1038/ng.2502
This article is cited by
-
Suppressing STAT5 signaling affects osteosarcoma growth and stemness
Cell Death & Disease (2020)